Arash Mostaghimi, MD, MPA, MPH, is an Assistant Professor of Dermatology, Director of the Dermatology Inpatient Service, and Co-Director of the Complex Medical Dermatology Fellowship at Brigham & Women’s Hospital.

Board-certified in Dermatology, Internal Medicine, and Clinical Informatics, Dr. Mostaghimi is a practicing physician specializing in the dermatologic care of inpatients and outpatients with complex dermatology disorders. His research centers on understanding variations in dermatologic care and improving care delivery to optimize resource utilization, encourage patient autonomy, and reduce disparities.

As the father of a daughter with alopecia areata, Dr. Mostaghimi is dedicated to clinical research focused on understanding the epidemiology, patient experience, and health system impact of this disease. He has developed multiple outcome measures used in alopecia areata studies, and is actively involved in translational research and clinical trials to develop novel therapeutics for patients with hair loss.

In addition to his research, Dr. Mostaghimi is a leader in dermatology education and has received multiple awards in recognition of his teaching and mentorship. With Dr. Kristina Liu, he co-hosts the podcast “Topical,” which is focused on providing trainees with a behind-the-scenes perspective on the careers of dermatologists.

Dr. Mostaghimi earned his medical degree and Master’s in Public Administration from Harvard Medical School and the Harvard Kennedy School in 2007. He completed his residency in Internal Medicine and Dermatology in the Beth Israel Deaconess Medical Center/Harvard Combined Program, where he also served as Chief Medical Resident. In 2013, he joined the Department of Dermatology at Brigham and Women’s Hospital. He also received a Master’s in Public Health from the Harvard T.H. Chan School of Public Health in 2015.

He is an advisor to multiple pharmaceuticals and startups with an emphasis on drug and device development, the financial and regulatory landscape of dermatology, artificial intelligence, and direct-to-consumer care.